ProfileGDS4718 / 229866_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 34% 47% 32% 25% 33% 29% 30% 30% 31% 25% 27% 27% 21% 32% 30% 29% 29% 27% 32% 30% 28% 31% 29% 32% 30% 31% 36% 28% 30% 27% 36% 30% 28% 36% 32% 36% 30% 31% 53% 30% 26% 41% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5623130
GSM549102patient 115, normal, homogenized [OPG study]4.7180934
GSM549104patient 119, normal, homogenized [OPG study]5.3580747
GSM549108patient 138, normal, homogenized [OPG study]4.6778632
GSM549119patient 077, normal, homogenized [OPG study]4.3473325
GSM549133patient 032, cancer, homogenized [OPG study]4.6106533
GSM549139patient 042, cancer, homogenized [OPG study]4.4768129
GSM549099patient 107, normal, homogenized [OPG study]4.5763130
GSM549109patient 139, normal, homogenized [OPG study]4.5838330
GSM549110patient 046, normal, homogenized [OPG study]4.5948231
GSM549114patient 063, normal, homogenized [OPG study]4.2963925
GSM549122patient 082, normal, homogenized [OPG study]4.4147727
GSM549134patient 033, cancer, homogenized [OPG study]4.4023827
GSM549136patient 036, cancer, homogenized [OPG study]4.1280321
GSM549140patient 044, cancer, homogenized [OPG study]4.57732
GSM549111patient 047, normal, homogenized [OPG study]4.5313730
GSM549113patient 057, normal, homogenized [OPG study]4.4393129
GSM549132patient 031, cancer, homogenized [OPG study]4.4852429
GSM549137patient 038, cancer, homogenized [OPG study]4.3943527
GSM549142patient 047, cancer, homogenized [OPG study]4.7423732
GSM549100patient 110, normal, homogenized [OPG study]4.5580630
GSM549107patient 135, normal, homogenized [OPG study]4.4364728
GSM549115patient 068, normal, homogenized [OPG study]4.5205631
GSM549116patient 072, normal, homogenized [OPG study]4.4725129
GSM549120patient 078, normal, homogenized [OPG study]4.6193532
GSM549131patient 030, cancer, homogenized [OPG study]4.4745130
GSM549118patient 074, normal, homogenized [OPG study]4.5705531
GSM549129patient 027, cancer, homogenized [OPG study]4.8205936
GSM549123patient 088, normal, homogenized [OPG study]4.4302528
GSM549124patient 006, cancer, homogenized [OPG study]4.5745330
GSM549126patient 015, cancer, homogenized [OPG study]4.3917627
GSM549128patient 025, cancer, homogenized [OPG study]4.7921636
GSM549103patient 117, normal, homogenized [OPG study]4.5929930
GSM549117patient 073, normal, homogenized [OPG study]4.4310128
GSM549138patient 041, cancer, homogenized [OPG study]4.7648336
GSM549141patient 045, cancer, homogenized [OPG study]4.5480532
GSM549130patient 028, cancer, homogenized [OPG study]4.7972836
GSM549101patient 111, normal, homogenized [OPG study]4.5619130
GSM549105patient 128, normal, homogenized [OPG study]4.5896731
GSM549106patient 134, normal, homogenized [OPG study]5.6178253
GSM549112patient 048, normal, homogenized [OPG study]4.5283430
GSM549125patient 011, cancer, homogenized [OPG study]4.3706926
GSM549127patient 024, cancer, homogenized [OPG study]5.057441
GSM549135patient 035, cancer, homogenized [OPG study]4.3168226